Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |